Shanghai Personal Biotechnology Co., Ltd.
PrivateCompany Overview
Shanghai Personal Biotechnology Co., Ltd. is a biotechnology company that provides genomic and proteomic sequencing services, including single-cell sequencing, microbiome analysis, and bioinformatics solutions for academic and pharmaceutical research.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Drug Discovery, Healthcare Analytics
Business Model
B2B
Customer Profile
Services & Consulting, Usage-Based SaaS
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Shanghai Personal Biotechnology Co., Ltd. Comparables
Compare Shanghai Personal Biotechnology Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Shanghai Majorbio Bio-pharm Technology Co., Ltd. | 92% | |
| Shanghai OE Biotech Co., Ltd. | 91% | |
| Beijing Biomarker Technologies Co., Ltd. | 89% | |
Shanghai Personal Biotechnology Co., Ltd. Funding Rounds
Historical fundraising activity
Market signals
Structured signals derived from secondary market and firmographic data.
- Feb 23, 2025
Grew 57% QoQ, from 21 to 33 employees.
Shanghai Personal Biotechnology Co., Ltd. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Shanghai Personal Biotechnology Co., Ltd.'s valuation, stock price, and market status.